NeurologyAugust 1, 2021
Immune Cells Suggest New Alzheimer’s Treatment Possibilities
Brain cells called microglia have different effects as the neurodegenerative disease progresses
Stories by David M. Holtzman
David M. Holtzman is professor and chair of neurology, scientific director of the Hope Center for Neurological Disorders at Washington University in St. Louis and associate director of the Knight Alzheimer's Disease Research Center. He is co-founder of C2N Diagnostics and has consulting arrangements with and research grants from various other companies.